Patent 11426348 was granted and assigned to Pacira Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.
Embodiments of the present application relate to compositions of multivesicular liposomes (MVLs) and commercial manufacturing processes for making bupivacaine MVLs.